Please wait
S-8 S-8 EX-FILING FEES 0001835579 ImageneBio, Inc. N/A Fees to be Paid Fees to be Paid Fees to be Paid Fees to be Paid 0001835579 2025-11-10 2025-11-10 0001835579 1 2025-11-10 2025-11-10 0001835579 2 2025-11-10 2025-11-10 0001835579 3 2025-11-10 2025-11-10 0001835579 4 2025-11-10 2025-11-10 iso4217:USD xbrli:pure xbrli:shares

Calculation of Filing Fee Tables

S-8

ImageneBio, Inc.

Table 1: Newly Registered Securities

Security Type

Security Class Title

Fee Calculation Rule

Amount Registered

Proposed Maximum Offering Price Per Unit

Maximum Aggregate Offering Price

Fee Rate

Amount of Registration Fee

1 Equity Common Stock, par value $0.001 per share to be issued pursuant to the Inmagene Biopharmaceuticals 2019 Stock Incentive Plan Other 455,938 $ 5.31 $ 2,421,030.78 0.0001381 $ 334.35
2 Equity Common Stock, par value $0.001 per share to be issued pursuant to the ImageneBio, Inc. 2025 Equity Incentive Plan Other 1,118,167 $ 8.20 $ 9,168,969.40 0.0001381 $ 1,266.24
3 Equity Common Stock, par value $0.001 per share to be issued pursuant to the ImageneBio, Inc. 2025 Employee Stock Purchase Plan Other 111,816 $ 6.97 $ 779,357.52 0.0001381 $ 107.63
4 Equity Common Stock, par value $0.001 per share to be issued pursuant to the ImageneBio, Inc. 2025 Equity Inducement Plan Other 589,585 $ 8.20 $ 4,834,597.00 0.0001381 $ 667.66

Total Offering Amounts:

$ 17,203,954.70

$ 2,375.88

Total Fee Offsets:

$ 0.00

Net Fee Due:

$ 2,375.88

Offering Note

1

Pursuant to Rule 416(a) under the Securities Act of 1933, as amended (the "Securities Act"), this Registration Statement shall also cover any additional shares of Common Stock ("Common Stock") of ImageneBio, Inc. (the "Registrant") that become issuable under the Registrant's 2019 Stock Incentive Plan (the "2019 Plan") by reason of any stock dividend, stock split, recapitalization or other similar transaction. The amount registered represents shares of Common Stock reserved for issuance upon the exercise of outstanding stock options granted under the 2019 Plan. The proposed maximum aggregate offering price per unit and proposed maximum aggregate offering price for the 455,938 shares of Common Stock reserved for issuance upon the exercise of outstanding stock options granted under the 2019 Plan are made pursuant to Rule 457(h)(1) of the Securities Act solely for purposes of calculating the registration fee, and are calculated using the weighted-average exercise price of such stock options of $5.31 per share.

2

Pursuant to Rule 416(a) under the Securities Act, this Registration Statement shall also cover any additional shares of Common Stock that become issuable under the Registrant's 2025 Equity Incentive Plan (the "2025 Plan") by reason of any stock dividend, stock split, recapitalization or other similar transaction. The amount registered represents shares of Common Stock reserved for future grant under the 2025 Plan. The 2025 Plan provides that the number of shares initially reserved for issuance under the 2025 Plan will automatically increase on January 1 of each year for a period of ten years, commencing on January 1, 2026 and ending on (and including) January 1, 2035, in an amount equal to 5% of the total number of shares of Capital Stock outstanding (as defined in the 2025 Plan) determined on December 31 of the preceding year, unless the Registrant's board of directors acts prior to January 1 of a given year to provide that the increase for such year will be a lesser number of shares. The proposed maximum aggregate offering price per unit and proposed maximum aggregate offering price for the 1,118,167 shares of Common Stock reserved for future grant under the 2025 Plan are made pursuant to Rule 457(h)(1) and Rule 457(c) of the Securities Act solely for purposes of calculating the registration fee, and are based upon the average of the high and low prices of the Common Stock on November 5, 2025, as reported on the Nasdaq Capital Market.

3

Pursuant to Rule 416(a) under the Securities Act, this Registration Statement shall also cover any additional shares of Common Stock that become issuable under the Registrant's 2025 Employee Stock Purchase Plan (the "2025 ESPP") by reason of any stock dividend, stock split, recapitalization or other similar transaction. The amount registered represents 111,816 shares of Common Stock reserved for future grant under the 2025 ESPP. The 2025 ESPP provides that the number of shares initially reserved for issuance under the 2025 ESPP will automatically increase on January 1 of each year for a period of up to ten years, beginning on January 1, 2026 and ending on (and including) January 1, 2035, by an amount equal to the lesser of (i) 1% of the total number of shares of Capital Stock outstanding (as defined in the 2025 ESPP) determined on December 31 of the preceding year, and (ii) 227,944 shares of Common Stock. Notwithstanding the foregoing, the Registrant's board of directors may act prior to January 1st of a given year to provide that there will be no January 1 increase in the share reserve for such calendar year or that the increase for such year will be a lesser number of shares. The proposed maximum aggregate offering price per unit and proposed maximum aggregate offering price for the 111,816 shares of Common Stock reserved for future grant under the 2025 ESPP are made pursuant to Rule 457(h)(1) and Rule 457(c) of the Securities Act solely for purposes of calculating the registration fee, and are based upon 85% of the average of the high and low prices of the Common Stock on November 5, 2025, as reported on the Nasdaq Capital Market, which is the percentage of the trading price per share applicable to purchasers under the 2025 ESPP.

4

Pursuant to Rule 416(a) under the Securities Act, this Registration Statement shall also cover any additional shares of Common Stock that become issuable under the Registrant's 2025 Equity Inducement Plan (the "Inducement Plan") by reason of any stock dividend, stock split, recapitalization or other similar transaction. The amount registered represents shares of Common Stock reserved for future grant under the Inducement Plan. The proposed maximum aggregate offering price per unit and proposed maximum aggregate offering price for the 589,585 shares of Common Stock reserved for future grant under the Inducement Plan are made pursuant to Rule 457(h)(1) and Rule 457(c) of the Securities Act solely for purposes of calculating the registration fee, and are based upon the average of the high and low prices of the Common Stock on November 5, 2025, as reported on the Nasdaq Capital Market.

Table 2: Fee Offset Claims and Sources ☑Not Applicable
Registrant or Filer Name Form or Filing Type File Number Initial Filing Date Filing Date Fee Offset Claimed Security Type Associated with Fee Offset Claimed Security Title Associated with Fee Offset Claimed Unsold Securities Associated with Fee Offset Claimed Unsold Aggregate Offering Amount Associated with Fee Offset Claimed Fee Paid with Fee Offset Source
Rule 457(p)
Fee Offset Claims N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A
Fee Offset Sources N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A